Valuation Nectar Lifesciences Limited

Stocks

Market Closed - NSE India S.E. 07:05:09 2026-10-01 EDT			5-day change	1st Jan Change
10.23 ^INR	-2.57%		-7.50%	-47.30%

09-18	Nectar Lifesciences Limited Appoints Dr. Gunmala Suri as A Non-Executive Non-Independent Director, Effective September 18, 2026	CI
08-15	Nectar Lifesciences Limited Changes Its Corporate Office in Chandigarh	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	4,171	5,393	3,577	6,761	5,147	1,807
Change	-	29.3%	-33.68%	89.03%	-23.88%	-64.9%
Enterprise Value (EV) ¹	12,945	13,810	10,936	12,914	10,769	555.6
Change	-	6.68%	-20.81%	18.08%	-16.6%	-94.84%
P/E	-5.69x	21.5x	-14.8x	137x	-4.53x	-0.69x
PBR	0.39x	0.5x	0.34x	0.63x	0.54x	0.31x
PEG	-	-0x	0x	-1x	0x	-0x
Capitalization / Revenue	0.27x	0.32x	0.23x	0.4x	0.31x	-
EV / Revenue	0.84x	0.83x	0.72x	0.77x	0.64x	-
EV / EBITDA	11.7x	8.71x	20.3x	8.43x	-41.3x	-0.63x
EV / EBIT	25.9x	13.6x	-211x	14x	-12.2x	-0.5x
EV / FCF	6.19x	-28.1x	42.1x	13.3x	-63x	0.11x
FCF Yield	16.2%	-3.56%	2.37%	7.5%	-1.59%	946%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-3.27	1.117	-1.08	0.22	-5.07	-13.4
Distribution rate	-	-	-	-	-	-
Net sales ¹	15,433	16,689	15,237	16,841	16,704	-
EBITDA ¹	1,102	1,586	539.5	1,531	-260.8	-884.9
EBIT ¹	499.9	1,016	-51.73	923.8	-884.7	-1,113
Net income ¹	-732.6	250.5	-241.8	49.95	-1,137	-2,929
Net Debt ¹	8,774	8,417	7,359	6,152	5,623	-1,251
Reference price ²	18.60	24.05	15.95	30.15	22.95	9.30
Nbr of stocks (in thousands)	224,261	224,261	224,261	224,261	224,261	194,261
Announcement Date	8/24/21	8/24/22	8/11/23	8/14/24	8/26/25	8/20/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
NECTAR LIFESCIENCES LIMITED	-	-	-	-	21.27M
ELI LILLY AND COMPANY	32.9x	11.93x	24.23x	0.6%	1,031B
JOHNSON & JOHNSON	29.45x	6.54x	18.31x	2.02%	638B
ABBVIE INC.	33.1x	7.75x	16.02x	2.65%	462B
MERCK & CO., INC.	105.72x	5.91x	25.05x	2.35%	359B
ROCHE HOLDING AG	19x	4.63x	11.48x	2.87%	335B
NOVARTIS AG	20.37x	5.28x	13.08x	3.03%	273B
ASTRAZENECA PLC	20.79x	4.31x	12.28x	2.05%	253B
AMGEN INC.	26.62x	6.92x	12.32x	2.39%	228B
GILEAD SCIENCES, INC.	-45.08x	6.57x	25.65x	2.21%	185B
Average	26.98x	6.65x	17.60x	2.24%	376.39B
Weighted average by Cap.	32.10x	7.72x	18.90x	1.92%